The Middle EAST Spinal Muscular Atrophy Treatment Market was valued at USD 0.45 billion in 2024 and is projected to reach USD 1.20 billion by 2034, registering a CAGR of 9.8%. This growth trajectory is underpinned by a combination of increasing awareness about spinal muscular atrophy (SMA), advancements in treatment modalities, and a rising prevalence of the condition within the region. The...